Teligent, Inc. (NASDAQ:TLGT) traded down 0% during trading on Tuesday following a dissappointing earnings announcement. The stock traded as low as $2.82 and last traded at $2.96. 8,354,505 shares traded hands during trading, an increase of 2,477% from the average session volume of 324,167 shares. The stock had previously closed at $2.96.

The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.07). The business had revenue of $13.65 million for the quarter, compared to the consensus estimate of $19.12 million. Teligent had a negative net margin of 16.95% and a negative return on equity of 6.38%. Teligent’s revenue was down 15.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.01 EPS.

Several equities analysts recently weighed in on the stock. Zacks Investment Research raised shares of Teligent from a “strong sell” rating to a “hold” rating in a research report on Friday, October 13th. Canaccord Genuity reaffirmed a “buy” rating and set a $11.00 price objective on shares of Teligent in a research report on Tuesday, August 8th. Roth Capital set a $9.00 price objective on shares of Teligent and gave the company a “buy” rating in a research report on Wednesday, August 23rd. BidaskClub lowered shares of Teligent from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Finally, Deutsche Bank AG reaffirmed a “hold” rating and set a $9.00 price objective (up previously from $8.00) on shares of Teligent in a research report on Monday, July 17th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $7.33.

Large investors have recently added to or reduced their stakes in the company. Parkwood LLC bought a new position in shares of Teligent in the second quarter valued at approximately $112,000. UBS Asset Management Americas Inc. bought a new position in shares of Teligent in the first quarter valued at approximately $170,000. Renaissance Technologies LLC bought a new position in shares of Teligent in the first quarter valued at approximately $198,000. American International Group Inc. raised its position in shares of Teligent by 7.1% in the first quarter. American International Group Inc. now owns 25,488 shares of the company’s stock valued at $199,000 after purchasing an additional 1,680 shares during the period. Finally, Voya Investment Management LLC raised its position in shares of Teligent by 16.1% in the second quarter. Voya Investment Management LLC now owns 23,342 shares of the company’s stock valued at $214,000 after purchasing an additional 3,234 shares during the period. 66.44% of the stock is currently owned by institutional investors.

The company has a quick ratio of 3.71, a current ratio of 4.37 and a debt-to-equity ratio of 1.99.

COPYRIGHT VIOLATION NOTICE: “Teligent, Inc. (TLGT) Shares Down 0% After Earnings Miss” was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/11/09/teligent-inc-tlgt-shares-down-0-after-earnings-miss.html.

Teligent Company Profile

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Receive News & Stock Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related stocks with our FREE daily email newsletter.